Citation Impact
Citing Papers
Surveillance of the Tumor Mutanome by T Cells during Progression from Primary to Recurrent Ovarian Cancer
2013
Single immunizations of self-amplifying or non-replicating mRNA-LNP vaccines control HPV-associated tumors in mice
2023 StandoutNobel
Phase Ib study evaluating a self-adjuvanted mRNA cancer vaccine (RNActive®) combined with local radiation as consolidation and maintenance treatment for patients with stage IV non-small cell lung cancer
2014
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
Metallothionein expression in ovarian cancer in relation to histopathological parameters and molecular markers of prognosis
2001
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Self-adjuvanted mRNA vaccination in advanced prostate cancer patients: a first-in-man phase I/IIa study
2015
Allergen immunotherapy for asthma
2003
Ovarian cancer: strategies for overcoming resistance to chemotherapy
2003
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Cisplatin resistance in human cancers
1991
Cisplatin: mode of cytotoxic action and molecular basis of resistance
2003 Standout
Lung surfactant proteins involved in innate immunity
1999
Molecular mechanisms of drug resistance
2005
Cancer drug resistance: an evolving paradigm
2013 Standout
The resurgence of platinum-based cancer chemotherapy
2007 Standout
Immunotherapy in asthma: an updated systematic review
1999
Recent advances in mRNA vaccine technology
2020 StandoutNobel
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Molecular mechanisms of cisplatin resistance
2011 Standout
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
2015 Standout
Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis
1999
Delivery technologies for cancer immunotherapy
2019 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
A Serpin Shapes the Extracellular Environment to Prevent Influenza A Virus Maturation
2015 StandoutNobel
Induction of Cytomegalovirus-Specific T Cell Responses in Healthy Volunteers and Allogeneic Stem Cell Recipients Using Vaccination With Messenger RNA–Transfected Dendritic Cells
2014
Cisplatin resistance: Preclinical findings and clinical implications
2010
A Ribosomopathy Reveals Decoding Defective Ribosomes Driving Human Dysmorphism
2017 StandoutNobel
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
NMR Structure of the Sea Urchin (Strongylocentrotus purpuratus) Metallothionein MTA
1999 StandoutNobel
Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study
2017
Metabolomics: the apogee of the omics trilogy
2012 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
mRNA-transfected dendritic cell vaccine in combination with metronomic cyclophosphamide as treatment for patients with advanced malignant melanoma
2016
DNA vaccine for cancer immunotherapy
2014
In vivo electroporation enhances vaccine-mediated therapeutic control of human papilloma virus-associated tumors by the activation of multifunctional and effector memory CD8+ T cells
2017
Mechanisms of acquired resistance to cisplatin
1994
Head and Neck Cancer
1993 Standout
Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line
1996 StandoutNobel
Regulation of insulin receptor function
2007
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Regulatory T cells in cancer immunotherapy
2014 StandoutNobel
Points of control in inflammation
2002 StandoutNature
Urinary tract infections: epidemiology, mechanisms of infection and treatment options
2015 Standout
Electroporation-enhanced delivery of nucleic acid vaccines
2014
Inhibition of Daptomycin by Pulmonary Surfactant: In Vitro Modeling and Clinical Impact
2005
New platinum antitumor complexes
1993
Shotgun lipidomics: Electrospray ionization mass spectrometric analysis and quantitation of cellular lipidomes directly from crude extracts of biological samples
2004
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Mechanisms of resistance to cisplatin
2001
Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
2009 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Hemolytic Phospholipase C Inhibition Protects Lung Function during Pseudomonas aeruginosa Infection
2011
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Insulin Signaling Diverges into Akt-dependent and -independent Signals to Regulate the Recruitment/Docking and the Fusion of GLUT4 Vesicles to the Plasma Membrane
2006
Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity
2017
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
2014 StandoutNobel
Current Status of Platinum-Based Antitumor Drugs
1999 Standout
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Surfactant Protein D Regulates NF-κB and Matrix Metalloproteinase Production in Alveolar Macrophages via Oxidant-Sensitive Pathways
2001
Surfactant Protein D Is Present in Human Tear Fluid and the Cornea and Inhibits Epithelial Cell Invasion byPseudomonas aeruginosa
2005
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Innate Defense against Influenza A Virus: Activity of Human Neutrophil Defensins and Interactions of Defensins with Surfactant Protein D
2006
Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice
2000
cis -Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects
2008 StandoutNobel
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Structure, Recognition, and Processing of Cisplatin−DNA Adducts
1999 Standout
Structure of P-Glycoprotein Reveals a Molecular Basis for Poly-Specific Drug Binding
2009 StandoutScience
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Immunobiologic Aspects of Head and Neck Cancer: Clinical and Laboratory Correlates
1991
Neoantigens in cancer immunotherapy
2015 StandoutScience
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Regulation of Glucose Transporter Translocation in Health and Diabetes
2012
Direct visualization at the single-cell level of siRNA electrotransfer into cancer cells
2011
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Photopharmacology: Beyond Proof of Principle
2014 StandoutNobel
Cutting Edge: CTLA-4 on Effector T Cells Inhibits In Trans
2012 StandoutNobel
Cell cycle regulation of metallothionein in human colonic cancer cells.
1995
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Corneal surface glycosylation is modulated by IL‐1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding
2017 StandoutNobel
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
2019
Works of Ann Mander being referenced
DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time
2012
Response definition criteria for ELISPOT assays revisited
2010
Idiotypic DNA vaccination for the treatment of multiple myeloma: safety and immunogenicity in a phase I clinical study
2015
Knock‐down of LAR protein tyrosine phosphatase induces insulin resistance
2005
Protein kinase-ζ interacts with munc18c: role in GLUT4 trafficking
2005
Metallothionein levels in ovarian tumours before and after chemotherapy
1991
Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program
2010
Deficient Hydrophilic Lung Surfactant Proteins A and D with Normal Surfactant Phospholipid Molecular Species in Cystic Fibrosis
1999
Altered Phospholipid Composition and Aggregate Structure of Lung Surfactant Is Associated with Impaired Lung Function in Young Children with Respiratory Infections
2002
DNA Vaccination with Electroporation Induces Increased Antibody Responses in Patients with Prostate Cancer
2009
IgE SERUM-LEVELS IN CANCER PATIENTS
1975
Improvement of fog and exercise-induced bronchoconstriction after local and subcutaneous immunotherapy in mite asthma.
1992